The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune checkpoint inhibitor–induced diabetes mellitus across NCI trials.
 
Zoe E. Quandt
Consulting or Advisory Role - Novartis
 
Vanessa Hill
No Relationships to Disclose
 
Joe E. Dib
No Relationships to Disclose
 
Jason Burian
No Relationships to Disclose
 
Sapir Tessler
No Relationships to Disclose
 
Abdul Rafeh Naqash
No Relationships to Disclose
 
Mark S Anderson
Stock and Other Ownership Interests - Medtronic; Merck
Consulting or Advisory Role - AbolerIS Pharma; Imcyse; Rubius Therapeutics; Sana Biotechnology
 
Megan Othus
Consulting or Advisory Role - Biosight; Cascadia Labs; Daiichi Sankyo; Glycomimetics; Merck
Other Relationship - Celgene; Glycomimetics
 
Elad Sharon
No Relationships to Disclose